Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Karuna Therapeutics, Inc.

KRTX•NASDAQ
Healthcare
Biotechnology
$329.83
$0.09(0.03%)
U.S. Market is Open • 15:50

Karuna Therapeutics, Inc. (KRTX) Stock Overview

Explore Karuna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.6B
P/E Ratio-28.11
EPS (TTM)$-11.74
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$407.12

KRTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Karuna Therapeutics, Inc. (KRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $407.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.11 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.03%
3-Month Change
4.13%
6-Month Change
92.87%
Year-to-Date (YTD) Change
4.79%
1-Year Change
80.59%
3-Year Change
185.72%
5-Year Change
1547.50%
All-Time (Max) Change
1547.50%

Contact Information

https://www.karunatx.com
857 449 2244
99 High Street, Boston, MA, 02110

Company Facts

3,390 Employees
IPO DateJun 28, 2019
CountryUS

Frequently Asked Questions